IDPC Progress Report 2015-2016. International Drug Policy Consortium (IDPC). (2016)

immage

The period covered by this progress report has been highly eventful, not least because of the recent UN General Assembly Special Session on Drugs (UNGASS) which was held in April 2016. It is also the year in which IDPC proudly commemorates our 10th anniversary. IDPC was officially founded in 2006 after a small group of civil society organisations identified a need for a global network to coordinate advocacy efforts for drug policy reform. Since then the IDPC membership has grown exponentially in size, diversity of issues, visibility, and influence. We welcomed our 150th member this past year and we are as committed as ever to collective and collaborative advocacy to advance genuine and lasting reform in drug policies. In early 2016, we also finalised our strategy for the coming five years (2016 to 2020) which builds on our work to date and commits us to redouble our efforts in regional and national level networking while ensuring a strong link to the global debates.

 

Keywords: drugs, harm reduction, UNGASS, civil society

 

Download Publication

Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users (FIDUs) in Kathmandu Valley Round I –2016 (Fact Sheet). National Centre for AIDS and STD Control. (2016)

immage

This is the first round of the IBBS survey conducted among Female Injecting Drug Users in Kathmandu Valley (Kathmandu, Lalitpur and Bhaktapur districts). The females of 16 years and above who had been injecting drugs for at least three months preceding the survey were defined as Female Injecting Drug Users and enrolled in the survey.

School of Planning Monitoring Evaluation and Research carried out this survey from April 2016 to July 2016. The survey was undertaken primarily to track the prevalence of HIV, syphilis, Hepatitis B and Hepatitis C Infection among Female Injecting Drug Users. The aim of the survey was to find out the baseline status of comprehensive knowledge of HIV/AIDS, risky sexual and injecting behaviors among Female Injecting Drug Users, their exposures to various HIV/AIDS prevention, treatment, care and support programs. The ethical approval for the survey was obtained from Nepal Health Research Council.


Keywords: Nepal, IBBS, HIV, drugs, prevalence, syphilis, hepatitis B and hepatitis C

 

Download Publication

Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users in Kathmandu Valley - Round I. National Centre for AIDS and STD Control. (2016)

immage

This is the first round of the IBBS survey conducted among Female Injecting Drug Users in Kathmandu Valley (Kathmandu, Lalitpur and Bhaktapur districts). A total of 160 females of 16 years and above who had been injecting drugs for at least three months preceding the survey were recruited randomly using Network sampling method.

The fieldwork for the survey was conducted from April to July 2016. The survey was undertaken primarily to track the prevalence of HIV, Syphilis, Hepatitis B and Hepatitis C infection among Female Injecting Drug Users. The aim of the survey was to find out the baseline status of comprehensive knowledge of HIVAID, risky sexual and injecting behaviors among Female Injecting Drug Users, their exposure to various HIV/AIDS prevention, treatment, care and support programs. The Information was collected using tablet based structured questionnaire and the prevalence of HIV, Syphilis, Hepatitis B and Hepatitis C was tested by using rapid kits.

 


Keywords: Nepal, HIV, HCV, STI, drugs, prevalence, sexual behavior, condom use

 

 

Download Publication

Integrated Biological and Behavioral Surveillance (IBBS) Survey among People Who Inject Drugs (PWID- Male) in Western to Far Western Terai Highway Districts of Nepal - Round V. National Centre for AIDS and STD Control. (2016)

immage

The National Centre for AIDS and STD Control (NCASC) conducts Integrated Biological behavioral survey at regular interval among Key Affected Populations (KAPs). The existing National HIV and AIDS Strategy (2011-2016) identifies that People who Inject Drugs (PWIDs), Female Sex Workers (FSWs) and their clients, Male Labor Migrants (MLMs) and their spouses, and Men who have Sex with Men (MSM) are the key affected populations (KAPs) (NCASC, 2014). The surveys help to assess the prevalence of HIV and AIDS and STIs among them and the risk behavior related to it.

This is the fifth round of survey conducted among males who inject drugs in 7 highway districts in Terai from Western to Far-western region of Nepal. A total of 300 men were selected as the sample among the ones who met the criteria of the study population. The study found that there is a prevalence of HIV, Syphilis, Hepatitis B and Hepatitis C in the study population. The drug injecting and sexual risk behavior related to HIV and AIDS, STIs, HBV and HCV was assessed and the knowledge of the PWIDs related to prevention of HIV and AIDS, STIs and HCV and their behavior seeking health care was also identified.

 

Keywords: Nepal, HIV, STI, PWID, hepatitis C, sexual behavior, treatment

 

Download Publication

Integrated Biological and Behavioral Surveillance (IBBS) Survey among People Who Inject Drugs (PWIDs) in Western to Far Western Terai Highway Districts of Nepal Round V - 2016. National Centre for AIDS and STD Control. (2016)

immage

This is the fifth round of Integrated Biological and Behavioral (IBBS) survey conducted among People who Inject Drugs (PWIDs) male in 7 Terai highway districts of Western, Mid-Western and Far-Western regions of Nepal. This survey finds out the prevalence of HIV, Syphilis, Hepatitis B and Hepatitis C. The drug injecting and sexual risk behavior related to HIV and AIDS, STIs, Hepatitis B and Hepatitis C has been assessed. The knowledge of the PWIDs related to prevention of HIV and AIDS, STIs and HCV and their health care seeking behavior has also been identified. A cross-sectional two-stage sampling methods were applied to recruit sample, where 300 samples were covered in this survey. This survey was carried out during February- March 2016.


Keywords: Nepal, IBBS, HIV, PWID, prevalence, hepatitis C, condom use

 

Download Publication

Key Populations taking the Lead. LINKAGES. (2016)

immage

In many countries, however, men who have sex with men, sex workers, transgender people, and people who inject drugs are taking the lead to ensure that their peers receive the services they need. This issue of The Link highlights some of these efforts as it examines the promise of peer-led and peer-assisted interventions designed to increase access to and uptake of HIV prevention, care, and treatment services.


Keywords: HIV/AIDS, harm reduction, stigma and discrimination, health services, key populations

Download Publication

People who Use Drugs: Stop TB Key Populations Brief. Stop TB Partnership. (2016)

immage

Globally, people who use drugs (PWUD) remain stigmatized and criminalized, which contributes to devastating health disparities, including extremely high rates of TB often combined with HIV and viral hepatitis. The range of these health issues and the prevailing lack of integrated health services capable of delivering TB, HIV, and harm reduction services in one place largely contribute to the scope of the TB crisis in communities of PWUD.


Keywords: TB, PWUD, HIV, advocacy, community, laws, policy, criminalization, treatment, stigma

Download Publication

Position Paper: Ending the HIV and Hepatitis C Epidemics among People who Inject Drugs. McLean S and et al. (2016)

immage

This is the Alliance's position paper on HIV, drugs and drug policy in the lead up to the UN General Assembly Special Session on the World Drug Problem, 2016.

The sharing of injecting equipment is driving HIV and hepatitis C (HCV) transmission in many parts of the world. Roughly one third of new HIV infections outside sub-Saharan Africa are the result of unsafe injecting. In 2014 alone, an estimated 110,000 people who inject drugs were newly infected with HIV.

The evidence for the effectiveness of harm reduction interventions is described by UNAIDS as irrefutable and all relevant UN agencies now endorse a harm reduction approach to HIV and drug use. Cost-effective harm reduction programmes that use peer-based outreach and feature clean needle and syringe programmes, opiate substitution therapy and HIV testing and treatment are proven to be effective in reducing HIV transmission and other harms such as hepatitis C transmission, crime rates and overdose deaths.

 

Keywords: HIV, testing, treatment, harm reduction, drug, police harassment, health services

 

Download publication

Readiness Assessment: Moving towards a Country-led and - Financed HIV Response for Key Populations. USAID, PEPFAR and Health Policy Project. (2016)

immage

This new guide from the USAID- and PEPFAR-funded Health Policy Project is a flexible tool for assessing the readiness and ability of country stakeholders (including government, development partners, and civil society) to sustain HIV epidemic control among key populations when donors transition to different levels and types of funding.


Keywords: guid, sex workers (SWs), men who have sex with men (MSM), transgender persons (TG), and people who inject drugs (PWID)

Download Publication

The Case for a Harm Reduction Decade. Cook C, Phelan M, Sander G, Stone K and Murphy F. (2016)

immage

HIV-related deaths and new HIV infections among people who inject drugs could be almost entirely eliminated by 2030 with just a tiny shift in global drug control spending. This is one finding of our report The Case for a Harm Reduction Decade.

The study uses data we have collected over the last 10 years for our biennial Global State of Harm Reduction reports to assess progress and reflect on challenges faced around the world. Using mathematical modelling, it then outlines the potential impact of increased investment in harm reduction on avoidable health-related harms associated with injecting drug use over the next decade and beyond.


Keywords: HIV, harm reduction, human rights, cost-effectiveness 

Download Publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Get_on_the_Fast-Track_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_July-Oct-AIDSreg2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_AIDS_by_the_numbers_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_Report_Punjab_2014_0.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/The_negative_impact_of_drug_control_on_public_health_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Death_Penalty_for_Drug_Offences_Global_Overview_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Consolidated_Strategic_Information_Guidelines_for_HIV_in_Health_Sector_2015.pdf
Calendar of events
Jul
28
(28 Jul - 28 Jul)
Aug
12
(12 Aug - 12 Aug)